Mataró, Barcelona, Spain, and Düsseldorf, Germany, 09 September 2026 - Minoryx Therapeutics and Neuraxpharm Group (Neuraxpharm), announce that the last patient has been enrolled in the global Phase 3 clinical...
Art Pappas joins a Venture Capital Panel at Mid-Atlantic Bio on September 28 in Bethesda, MD.
News | 08. 20. 2012
Art Pappas joins a Venture Capital Panel at Mid-Atlantic Bio on September 28 in Bethesda, MD.
